Now that the Phase 2/3b trials have begun and the speed at which the patients seem to respond, the initial data of survival after 14 days along with improvement data on shorter duration patients (typically in 3 days) should be overwhelming proof that this drug is needed ASAP.

As NP had said in one of his press statements or TV interviews, that in such a case he will immediately request an interim review by the FDA. I will not be surprised that the interim assessment by investigators will be very positive. This will put a lot of pressure on the FDA to let the placebo patients who are not responding or getting worse to also be given Leronlimab. Do I dare dream of the PH2 trial for the severe patients would morph into an unlimited Emergency Use IND?

Lastly, to those who post regarding our PR quality and clarity (I really have to wonder...), I can only say that the final proof is in the effectiveness. In the last two weeks there has been an EXPLOSION of both domestic and international TV and print coverage of Cytodyn and Leronlimab. US and Global TV news coverage, where our message seems to keep improving, is a form of free advertising that only Elon Musk seems to get!

Go CYDY and Nader P.!